Aquatic Capital Management LLC Kodiak Sciences Inc. Transaction History

Aquatic Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.05 $69,764 - $86,135	-10,700 Reduced 87.7%	1,500 $11,000
Q3 2022 Nov 14, 2022	BUY	$7.57 - $12.5 $92,354 - $152,500	12,200 New	12,200 $94,000
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.48 $1,008 - $1,896	-200 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.09 - $89.45 $709 - $8,945	-100 Reduced 33.33%	200 $2,000
Q4 2021 Feb 14, 2022	BUY	$80.85 - $128.49 $24,255 - $38,547	300 New	300 $25,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $303M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.